Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' Study.
Laurino M, Loron S, Larcher MV, Fossard G, Elhamri M, Deloire A, Balsat M, Barraco F, Labussière H, Ducastelle S, Renault M, Wattel E, Heiblig M, Salles G, Thomas X. Laurino M, et al. Among authors: balsat m. Mediterr J Hematol Infect Dis. 2020 May 1;12(1):e2020020. doi: 10.4084/MJHID.2020.020. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 32395209 Free PMC article.
Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
Mohamed AM, Balsat M, Thenoz M, Koering C, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Michallet M, Thomas X, Nicolini F, Solly F, Guyotat D, Campos L, Wattel E, Mortreux F. Mohamed AM, et al. Among authors: balsat m. Oncotarget. 2016 Jan 19;7(3):2889-909. doi: 10.18632/oncotarget.3898. Oncotarget. 2016. PMID: 26284582 Free PMC article.
Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients.
Fossard G, Blond E, Balsat M, Morisset S, Giraudier S, Escoffre-Barbe M, Labussière-Wallet H, Heiblig M, Bert A, Etienne M, Drai J, Sobh M, Redonnet-Vernhet I, Lega JC, Mahon FX, Etienne G, Nicolini FE. Fossard G, et al. Among authors: balsat m. Haematologica. 2016 Mar;101(3):e86-90. doi: 10.3324/haematol.2015.135103. Epub 2015 Dec 3. Haematologica. 2016. PMID: 26635034 Free PMC article. No abstract available.
A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.
Conrad A, Le Maréchal M, Dupont D, Ducastelle-Leprêtre S, Balsat M, Labussière-Wallet H, Barraco F, Nicolini FE, Thomas X, Gilis L, Chidiac C, Ferry T, Wallet F, Rabodonirina M, Salles G, Michallet M, Ader F; Lyon HEMINF study Group. Conrad A, et al. Among authors: balsat m. Clin Microbiol Infect. 2016 Jul;22(7):636-41. doi: 10.1016/j.cmi.2016.04.025. Epub 2016 May 10. Clin Microbiol Infect. 2016. PMID: 27172809 Free article.
Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
Heiblig M, Le Jeune C, Elhamri M, Balsat M, Tigaud I, Plesa A, Barraco F, Labussière H, Ducastelle S, Nicolini F, Wattel E, Salles G, Thomas X. Heiblig M, et al. Among authors: balsat m. Leuk Lymphoma. 2017 Jan;58(1):110-117. doi: 10.1080/10428194.2016.1180688. Epub 2016 May 17. Leuk Lymphoma. 2017. PMID: 27184036
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.
Balsat M, Renneville A, Thomas X, de Botton S, Caillot D, Marceau A, Lemasle E, Marolleau JP, Nibourel O, Berthon C, Raffoux E, Pigneux A, Rodriguez C, Vey N, Cayuela JM, Hayette S, Braun T, Coudé MM, Terre C, Celli-Lebras K, Dombret H, Preudhomme C, Boissel N. Balsat M, et al. J Clin Oncol. 2017 Jan 10;35(2):185-193. doi: 10.1200/JCO.2016.67.1875. Epub 2016 Nov 14. J Clin Oncol. 2017. PMID: 28056203
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.
Mohamed AM, Balsat M, Koering C, Maucort-Boulch D, Boissel N, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Tigaud I, Hayette S, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet M, Ceraulo A, Mortreux F, Wattel E. Mohamed AM, et al. Among authors: balsat m. Leuk Res. 2017 May;56:21-28. doi: 10.1016/j.leukres.2017.01.012. Epub 2017 Jan 16. Leuk Res. 2017. PMID: 28167452
Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience.
Heiblig M, Labussière-Wallet H, Nicolini FE, Michallet M, Hayette S, Sujobert P, Plesa A, Balsat M, Paubelle E, Barraco F, Tigaud I, Ducastelle S, Wattel E, Salles G, Thomas X. Heiblig M, et al. Among authors: balsat m. Cancers (Basel). 2019 Apr 22;11(4):570. doi: 10.3390/cancers11040570. Cancers (Basel). 2019. PMID: 31013658 Free PMC article.
50 results